Charles River Labs has added another string to its early-stage R&D bow by acquiring preclinical services specialist Citoxlab for around $510 million in cash.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,